EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Inhibition of TRPM3 by Primidone Provides a Potential Therapeutic Method for Adenomyosis Management

Zhixing Jin iD, Yaoming Peng, He Zhang, Xiaoping He, Yi Zhang, Xin Pan, Min Li, Qianqian Yang

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s494981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Zhixing Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215123, People's Republic of China. Hauptthemen laut MEDLINE: Adenomyosis, TRPM Cation Channels, Pyrimidinones. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To test the expression profile of transient receptor potential channels (TRPs) in adenomyosis patients and evaluate the effects of primidone on tamoxifen-induced adenomyosis mice. Patients and Methods: This study included in vivo animal model and human tissue samples. Eutopic endometrium from adenomyosis patients (n=20) was collected and subjected to mRNA analysis of TRP channels. TRPA1, TRPV1 and TRPM3 in adenomyosis patients (n=50) and tamoxifen-induced adenomyosis mice (n=6) were examined by immunohistochemistry. From 10 weeks after birth, primidone (2 mg/kg/d) and atosiban (1 mg/kg/d) were given separately to adenomyotic mice by intraperitoneal injection for 3 weeks. The hotplate test was conducted once a week beginning at 10 weeks, and then uterine samples were harvested for HE staining and RNA-seq at 13 weeks.

Results

The mRNA expression of 15 TRPs was significantly increased in the proliferative phase of the adenomyotic endometrium. TRPV1, TRPM3 or TRPA1 staining levels were positively correlated with dysmenorrhea severity, menses amount and uterine size. In tamoxifen-induced adenomyosis mice, primidone had a significant effect on both the depth of myometrial infiltration and analgesia. Forty-seven DEGSSs were identifieSd after primidone treatment, and bioinformatics analysis predicted that they were enriched in the cell cycle and cell division.

Conclusion

The expression profile of TRP channels varies significantly in adenomyosis patients, and primidone may provide a potential therapeutic method for adenomyosis management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenomyosisTRPM Cation ChannelsPyrimidinonesAnimalsFemaleHumansMiceTamoxifenAdultDisease Models, Animal

Stichwörter der Autor:innen

TRPM3TRPsadenomyosispelvic painprimidone

Substanzen

TRPM Cation ChannelsTamoxifenPyrimidinonesTRPM3 protein, humanTRPM3 protein, mouse

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215123, People's Republic of China.
  • Shanghai Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, People's Republic of China.
  • Department of Pathology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215123, People's Republic of China.

ORCID-Profile: Zhixing Jin

Zitieren

APA

Jin, Z., Peng, Y., Zhang, H., He, X., Zhang, Y., Pan, X., Li, M., & Yang, Q. (2025). Inhibition of TRPM3 by Primidone Provides a Potential Therapeutic Method for Adenomyosis Management. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s494981

Vancouver

Jin Z, Peng Y, Zhang H, He X, Zhang Y, Pan X, et al. Inhibition of TRPM3 by Primidone Provides a Potential Therapeutic Method for Adenomyosis Management. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s494981

BibTeX
@article{Jin2025,
  author = {Jin, Zhixing and Peng, Yaoming and Zhang, He and He, Xiaoping and Zhang, Yi and Pan, Xin and Li, Min and Yang, Qianqian},
  title = {Inhibition of TRPM3 by Primidone Provides a Potential Therapeutic Method for Adenomyosis Management},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s494981}
}
Kostenlos starten →